Patents Assigned to Lilac Therapeutics, Inc.
  • Acyclic thiol prodrugs
    Patent number: 11981694
    Abstract: Disclosed herein are acyclic thiol prodrugs, and pharmaceutical compositions thereof. The prodrugs and pharmaceutical compositions thereof may be used to treat or prevent medical disorders such as, for example cystinosis, cystinuria, cancer neurodegenerative disease, Parkinson's disease, Huntington's disease, malaria, nonalcoholic fatty liver disease, radiation poisoning, arsenic poisoning, radioprotection, Wilson's disease or rheumatoid arthritis.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: May 14, 2024
    Assignee: Lilac Therapeutics, Inc.
    Inventors: Manoj Chandrasinhji Desai, Siva R. Kamma
  • Cyclic thiol prodrugs
    Patent number: 11932665
    Abstract: Disclosed herein are cyclic thiol prodrugs, and pharmaceutical compositions thereof. The prodrugs and pharmaceutical compositions thereof may be used to treat or prevent medical disorders such as, for example, cystinuria, cystinosis, cancer, neurodegenerative disease, Parkinson's disease, Huntington's disease, malaria, nonalcoholic fatty liver disease, radiation poisoning, arsenic poisoning, radioprotection, Wilson's disease or rheumatoid arthritis.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: March 19, 2024
    Assignee: Lilac Therapeutics, Inc.
    Inventors: Manoj Chandrasinhji Desai, Siva R. Kamma
  • Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
    Patent number: 11806335
    Abstract: The present disclosure relates generally to modulators of human glycolate oxidase enzyme and methods of use and manufacture thereof.
    Type: Grant
    Filed: October 27, 2020
    Date of Patent: November 7, 2023
    Assignee: Lilac Therapeutics, Inc.
    Inventors: Hongyan Guo, Amy S. Lee, Hyung-Jung Pyun, Devleena M. Shivakumar, Manoj C. Desai, Lianhong Xu, John E. Knox, Zachary E R Newby